clinical trials

News

NeuroSense says ALS drug extends survival

NeuroSense Therapeutics is currently facing de-listing from the Nasdaq, so encouraging data from a phase 2b trial of its PrimeC drug candidate for amyotrophic lateral sclerosis (ALS) comes

Patients

Why informed patient consent is vital for successful clinica...

Informed consent is vital for any clinical trial.

News

J&J adds another string to nipocalimab bow with gMG data

Johnson & Johnson has reported new phase 3 data with its FcRn blocker nipocalimab in generalised myasthenia gravis (gMG), pointing to data that it says differentiates it from other drug

News

FDA reveals diversity action plan guide for clinical trials

The FDA has published its long-awaited update to guidance to make sure clinical trials more closely reflect the range of patients that might be treated with a new therapy in the real world.

News

Mistrust in healthcare is hitting clinical trial enrolment

A survey of pharma industry executives has found that a third of them believe mistrust in the healthcare system has become a significant barrier to getting a diverse range of people to sign

News

Imfinzi fails lung cancer trial, but scores in bladder cance...

AstraZeneca’s hopes of positioning its PD-L1 inhibitor Imfinzi as a post-surgery therapy for people with earlier-stage lung cancer have taken a knock, although it performed well in a bladde

NeuroSense says ALS drug extends survival

Why informed patient consent is vital for successful clinica...

J&J adds another string to nipocalimab bow with gMG data

FDA reveals diversity action plan guide for clinical trials

Mistrust in healthcare is hitting clinical trial enrolment

Imfinzi fails lung cancer trial, but scores in bladder cance...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

clinical trials

Editor's Picks